Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
A wide-market index fund retirement portfolio emphasizes broad market coverage, aiming for steady growth with manageable fees.
28,259 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Orbital Industries closes a $50 million Series B to accelerate AI-powered materials discovery and move toward selling...
A bold new plan could reshape crypto funding: a $300 million preferred stock sale to back an ETH-heavy treasury built...
BitMine plans a $300 million perpetual preferred stock sale to acquire ETH, expand staking infrastructure, and invest...
Major brokerages issued new research on top names like Airbnb, Broadcom, Chipotle, and NVIDIA as investors rotate str...
A delayed earnings release and a premium acquisition sparked a slide in Valaris shares. This article breaks down what...
Bitmine filed for a public offering of 3 million shares of a 9.50% perpetual preferred stock to accelerate ETH holdin...
Vitalik Buterin has surpassed his 16,384 ETH selling target, lifting total disposals beyond 18,000 ETH and valued at ...
A renewed policy debate on redistributing elon musk’s trillion raises questions about liquidity, feasibility, and the...
Autonomous AI agents are moving beyond chatbots to do complex tasks. This article explains why the agentic market cou...
On this stock market today, june, Microsoft shares slipped as AI spending scrutiny intensified amid Xbox restructurin...
June brought a tech-focused pullback as Apple raised device prices to offset memory costs. This deep dive explains wh...